Anbio Biotechnology Class A Ordinary Shares Detailed Financials

Full historical quarterly statements

Metric	2025-12-31	2025-09-30	2025-06-30	2024-12-31	2024-06-30	2023-12-31	2023-06-30
Total Revenue	4.7M	2.0M	5.0M	2.5M	6.3M	4.0M	3.3M
Cost of Goods Sold	877K	376K	384K	391K	2.1M	2.3M	1.4M
Gross Profit	3.9M	1.7M	4.6M	2.1M	4.2M	1.7M	1.9M
R&D Expenses	82K	35K	143K	353K	138K	146K	0
Operating Expenses	1.1M	455K	945K	3.9M	338K	1.1M	406K
Operating Income	2.8M	1.2M	3.7M	-1.7M	3.9M	584K	1.5M
Other Income / Gains	239K	103K	470K	410K	-2K	209K	107K
Net Income	3.0M	1.3M	4.1M	-1.3M	3.9M	793K	1.6M
EPS (Diluted)	0.069	0.03	0.095	-0.031	0.092	0.019	0.039
Reported Currency	USD	USD	USD	USD	USD	USD	USD
Gross Profit Ratio	0.815	0.815	0.923	0.846	0.669	0.428	0.587
General And Administrative Expenses	0	0	0	0	0	0	0
Selling And Marketing Expenses	0	0	0	0	0	0	0
Selling General And Administrative Expenses	980K	420K	802K	3.5M	199K	962K	406K
Other Expenses	0	0	1.00	0	0	0	0
Cost And Expenses	1.9M	831K	1.3M	-4.3M	-2.4M	-3.4M	-1.8M
Interest Income	2K	0	153K	215K	150K	160K	19K
Interest Expense	0	0	0	0	0	0	0
Depreciation And Amortization	0	-1.2M	0	0	0	4K	9K
Ebitda	2.8M	0	3.7M	-1.3M	3.9M	796K	1.7M
Ebitdaratio	0.591	0	0.734	-0.524	0.615	0.202	0.50
Operating Income Ratio	0.591	0.591	0.734	-0.686	0.615	0.148	0.465
Income Before Tax	3.0M	1.3M	4.1M	-1.3M	3.9M	793K	1.6M
Income Before Tax Ratio	0.641	0.641	0.828	-0.524	0.615	0.201	0.497
Income Tax Expense	0	0	0	0	0	0	0
Net Income Ratio	0.641	0.641	0.828	-0.524	0.615	0.201	0.497
Epsdiluted	0.069	0.03	0.095	-0.031	0.092	0.019	0.039
Weighted Average Shs Out	43.9M	43.9M	43.9M	42.3M	42.3M	42.3M	42.3M
Weighted Average Shs Out Dil	43.9M	43.9M	43.9M	42.3M	42.3M	42.3M	42.3M